Molecular detection of Trichomonas vaginalis from vaginal swabs collected in Copan Transystem

Amies gel without charcoal Molecular diagnostics Sexually transmitted infections Trichomonas vaginalis

Journal

Diagnostic microbiology and infectious disease
ISSN: 1879-0070
Titre abrégé: Diagn Microbiol Infect Dis
Pays: United States
ID NLM: 8305899

Informations de publication

Date de publication:
17 Nov 2023
Historique:
received: 23 08 2023
revised: 05 11 2023
accepted: 14 11 2023
medline: 27 11 2023
pubmed: 27 11 2023
entrez: 26 11 2023
Statut: aheadofprint

Résumé

We evaluated the performance of the Copan Transystem™ M40 collection swab containing Amies agar gel ('M40') on the Aptima® TV Assay for the detection of Trichomonas vaginalis ribosomal RNA (rRNA) using a novel 'Single Swab' molecular workflow. Overall agreement between Aptima TV Assay and wet mount microscopy was 99 % (152/153; 95 % confidence interval 0.9806 to 1.006), a positive agreement of 100 % and negative agreement of 99 %. Limit of detection for microscopy was 100,000-fold higher compared to molecular. T. vaginalis rRNA was stable in M40 under room-temperature and refrigerated conditions. The 'Single Swab' workflow resulted in a 57.4 % reduction in hands-on time, and a 5-fold increase in technologist productivity. Post-molecular test implementation analysis demonstrated a 2.27-fold increase in T. vaginalis positivity rate compared to the pre-implementation method. Collectively, our 'Single Swab' molecular testing approach was non-inferior to wet mount microscopy with the added benefits of a simplified and more efficient workflow.

Identifiants

pubmed: 38007913
pii: S0732-8893(23)00249-3
doi: 10.1016/j.diagmicrobio.2023.116140
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

116140

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest MAS, JL, AP and LWG are employees of Dynacare (a subsidiary of Laboratory Corporation of America), which is a private, for-profit laboratory that offers diagnostic testing services to government and non-government clients. While the individuals noted herein will not personally benefit from this submission, the company could benefit financially if the test is commercially marketed. No other potential conflicts of interest are reported.

Auteurs

Mihaela Anca Serbanescu (MA)

Dynacare Laboratory, Brampton, ON, L6T 5M3, Canada. Electronic address: serbanescum@dynacare.ca.

Jennie Limayo (J)

Dynacare Laboratory, Brampton, ON, L6T 5M3, Canada.

Alexandra Parks (A)

Dynacare Laboratory, Brampton, ON, L6T 5M3, Canada.

Lee W Goneau (LW)

Dynacare Laboratory, Brampton, ON, L6T 5M3, Canada; Department of Laboratory Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada.

Classifications MeSH